Wednesday, 21 November 2018

FDA approves Pfizer's treatment for rare blood cancer

The U.S. Food and Drug Administration said on Wednesday it approved Pfizer Inc's treatment for a rare form of blood cancer in some adults.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)